Resources for Patent: Pharmaceuticals & Biotechnology

Intellectual Property Advisory: Effective Timeline for the America Invents Act

America Invents Act Revamps US Patent Law

Robert L. Kovelman, Douglas R. Peterson
September 1, 2011

Intellectual Property Advisory - Recent Bills (Re)Introduced in Congress Directed to Pharmaceutical Companies

Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
March 30, 2009

Intellectual Property Advisory - FDA Denies 30-Month Stay of Approval of Certain ANDAs Under the QI-Act

Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
March 23, 2009

Intellectual Property Advisory - Amendments to Chinese Patent Law Affecting Pharmaceutical and Biotech Companies

Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
February 16, 2009

Intellectual Property Advisory - New Requirements for Submission of Bioequivalence Data for Generic Drug Applications

Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
January 28, 2009

Press Release Announcing Settlement with Eli Lilly & Co.

Eliot Spitzer
July 25, 2002

Critical Infrastructure Protection

Significant Homeland Security Challenges Need to be Addressed
United States General Accounting Office
July 9, 2002